Nuclear Medicine Market Worth USD 15.8 Million by 2025 | CAGR of 10.1%

The MarketWatch News Department was not involved in the creation of this content.

Dec 03, 2020 (Heraldkeepers) —
The latest report pertaining to ‘Nuclear Medicine Market’ provides a detailed analysis regarding market size, revenue estimations and growth rate of the industry. In addition, the report illustrates the major obstacles and newest growth strategies adopted by leading manufacturers who are a part of the competitive landscape of this market.

Nuclear Medicine Market is valued at USD 8.12 Million in 2018 and expected to reach USD 15.8 Million by 2025 with CAGR of 10.1% over the forecast period.

Get Sample Copy of This Premium Report https://brandessenceresearch.com/requestSample/PostId/406

**The sample pages of this report is immediately accessible on-demand.**

Top Nuclear Medicine Companies

Nuclear Medicine Market Report covers prominent players are like,

  • Bracco Imaging S.P.A.
  • Cambridge Isotope Laboratories, Inc
  • Cardinal Health, Inc.
  • Covidien, Plc
  • Eczacibasi-Monrol
  • Fujifilm Holdings Corporation
  • GE Healthcare (Subsidiary Of General Electric Company)
  • IBA Group
  • Isotec, Ntp Radioisotopes (Pty), Ltd
  • Siemens Healthcare (Subsidiary Of Siemens AG)
  • Taiyo Nippon Sanso Corporation
  • Urenco Limited
  • Rotem Industries, Ltd., Inc.

Nuclear Medicine Market report is segmented on the basis of type, procedural volumes, application, end-user and regional & country level. Based upon type, nuclear medicine market is classified as diagnostic nuclear medicine, therapeutic nuclear medicine, research nuclear medicine and other. Based upon procedural volumes, nuclear medicine market is classified into diagnostic procedures, therapeutic procedures and other. Based upon application, nuclear medicine market is classified into oncology, cardiology, neurology, thyroid, lymphoma, endocrinology and other. Based upon end-user, nuclear medicine market is classified into diagnostic centers, hospitals, research centers and other.

Market Analysis of Nuclear Medicine-

Nuclear medicine is involving the application of radioactive substances in the diagnosis and treatment of various diseases. Nuclear Medicine images can support the physician in diagnosing of many diseases and conditions such as analyze kidney and spleen function, image blood flow and function of the heart and scan the lungs for respiratory and blood-flow problems. Nuclear medicine uses radioactive materials helps to diagnose and treat a wide variety of diseases and disorders. It provides unique information about the human body and health. Nowadays nuclear medicine is expected to be the most sensitive approach to measure in vivo physiology, biochemistry and metabolism. The future development of nuclear medicine depends on an infrastructure of physics, mathematics and chemical biology.

The regions covered in this Global Nuclear Medicine market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Nuclear Medicine is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Global Nuclear Medicine market Report covers prominent players are like Bracco Imaging S.P.A., Cambridge Isotope Laboratories, Inc., Cardinal Health, Inc., Covidien, Plc, Eczacibasi-Monrol, Fujifilm Holdings Corporation, GE Healthcare (Subsidiary Of General Electric Company), IBA Group, Isotec, Ntp Radioisotopes (Pty), Ltd., Siemens Healthcare (Subsidiary Of Siemens AG), Taiyo Nippon Sanso Corporation, Urenco Limited, Rotem Industries, Ltd., Inc. and others.

Increasing prevalence of anxiety and diagnosis of various

Read more

The Only ‘Cyber Week’ Health and Fitness Deals Worth Knowing About

It’s official — Black Friday 2020 is upon us. With more deals, bargains and discounts than you could shake a shaker at, it can be hard to cut through the noise of endless reams of retailers promising to save you money before Christmas shopping kicks in.



a close up of a camera: We've cut through the noise to bring you the very best health, fitness and wellness deals


© Provided by Men’s Health UK
We’ve cut through the noise to bring you the very best health, fitness and wellness deals

Men’s Health, as ever, is here to help dilute the millions of deals into a tangible buyer’s guide for the man who enjoys exercising, using new tech and, of course, saving money.

Below, we’ve rounded up our most popular articles for Black Friday 2020, including Nike discount codes, low-key Under Armour sales, next-gen smartwatches, workout-proof headphones, discounted protein powder — including Optimum Nutrition, Bulk Powders, Myprotein and Maximuscle, gym swag from Lululemon, Reebok and Fitbit, WFH-proof coffee machines and many more besides . You’ll find them all below.

Sign up to the Men’s Health newsletter and kickstart your home body plan. Make positive steps to become healthier and mentally strong with all the best fitness, muscle-building and nutrition advice delivered to your inbox.

SIGN UP

For effective home workouts, uplifting stories, easy recipes and advice you can trust, subscribe to Men’s Health UK today

SUBSCRIBE

Source Article

Read more

The Only Black Friday Health and Fitness Deals Worth Knowing About

It’s official — Black Friday 2020 is upon us. With more deals, bargains and discounts than you could shake a shaker at, it can be hard to cut through the noise of endless reams of retailers promising to save you money before Christmas shopping kicks in.



a close up of a camera: We've cut through the noise to bring you the very best health, fitness and wellness deals


© Provided by Men’s Health UK
We’ve cut through the noise to bring you the very best health, fitness and wellness deals

Men’s Health, as ever, is here to help dilute the millions of deals into a tangible buyer’s guide for the man who enjoys exercising, using new tech and, of course, saving money.

Below, we’ve rounded up 12 of our most popular articles for Black Friday 2020, including Nike discount codes, low-key Under Armour sales, next-gen smartwatches, workout-proof headphones, discounted protein powder — including Optimum Nutrition, Bulk Powders, Myprotein and Maximuscle, gym swag from Lululemon, Reebok and Fitbit, WFH-proof coffee machines and many more besides . You’ll find them all below.

Gallery: Small daily habits for a more active lifestyle (Espresso)

Sign up to the Men’s Health newsletter and kickstart your home body plan. Make positive steps to become healthier and mentally strong with all the best fitness, muscle-building and nutrition advice delivered to your inbox.

SIGN UP

For effective home workouts, uplifting stories, easy recipes and advice you can trust, subscribe to Men’s Health UK today

SUBSCRIBE

Source Article

Read more

Black Friday Vitamin Sales Worth Shopping, From a Doctor

The supplements aisle contains a dizzying amount of products. (Valerian root? Horny goat weed?) Come Black Friday, you’ll be able to shop plenty of these dietary supplements at a major price cut. To help you sort through what’s worth your dollars—and what simply is not—I consulted Matthew Kohler, MD, and Rajivan Maniam, MD, functional medicine doctors and co-founders of Ospina Medical in New York City.

Despite the countless options on the shelf, Dr. Kohler and Dr. Maniam say the average person really only needs to consider five supplements. As always, you should consult your own doctor before adding new supplements to your diet.

The vitamins and supplements to buy on Black Friday

1. Vitamin D

black friday vitamin sales
Photo: Swanson Vitamins

“Vitamin D, the ‘sunshine vitamin,’ has long been pinned as one of the most common vitamin deficiencies that many of us suffer from,” says Dr. Maniam. “While seemingly benign, deficiency in Vitamin D may in fact be propagating pain. To date, there are several observational studies showing an association between vitamin D deficiency and different pain conditions including low back pain, menstrual cramps, and chronic pain.” Dr. Maniam adds that taking vitamin D supplements has the possibility of offering many positives with no known negative side effects, so hey, it’s worth a shot!

Shop Black Friday sale: Vitamin D, $10 (originally $12)

2. Vitamin B12

Photo: HUM

Vitamin B12 is like catnip for the brain—and Dr. Kohler recommends it for anyone who wants some extra cognitive sharpness. “Vitamin B12 is essential for many biological functions and offers numerous known benefits including energy production and assisting in more efficient cellular reproduction,” he says.  B12 is also credited with improving your mood, supporting fetal development, and improving memory—so yeah, it’s worth adding to your medicine cabinet with your doc’s okay.

Shop Black Friday sale: Vitamin B12, up to 50 percent off $10

3. Vitamin C

black friday vitamin sales
Photo: Ancient Nutrition

Vitamin C may be best known for its immune system-boosting abilities, but Dr. Kohler recommends it for another reason. “Vitamin C is a critical nutrient for patients with pain or recent injuries—not only for its anti-inflammatory, antioxidant, and pain-relieving abilities but also for its role in tissue repair and regeneration,” says Dr. Kohler. “Vitamin C helps accelerate the healing process and protects the body from free radical damage. This becomes especially important in patients who have sports injuries such as tendonitis or ligament sprains.” Athletes, this supplement’s for you.

Shop Black Friday sale: Ancient Nutrients Vitamin C + Probiotics, $14 (originally $19)

4. Vitamin K

Photo: Swanson

“Vitamin K works as an enzyme cofactor that has been implicated in inflammation, cardiovascular disease, and osteoarthritis,” says Dr. Maniam. “Inflammation is recognized as a crucial component of many chronic aging diseases and evidence suggests vitamin K has an anti-inflammatory action.”

Shop Black Friday sale: Swanson K-2, Buy one at $10 and get one free

4. Vitamin E

black friday vitamin sales
Photo: HUM

Dr. Maniam says vitamin C is another one that’s essential for anyone who takes their workout

Read more

How to Tell Which Fitness Influencers Are Worth Trusting

Fitness Instagram, like every other place or population on earth, contains multitudes. There are athletes working their butts off, coaches promoting their business, models making a living. Not all of these people are legitimate fitness professionals, so if you look to Insta or YouTube for workout advice you need to ask yourself a few questions.

What is this person implying but not saying?

The number one lie of many fitness influencers is one they leave unsaid: It is the implication that whatever I am selling will get you the body you see here.

The truth is, people who make a living by being fit all got fit before they started selling workout programs or supplements. Once you have a jacked physique, you can endorse sawdust in a jar and people will connect the dots in their mind to assume that you’re selling them a muscle building supplement. If you have a lean body, you can sell a diet plan and people will assume that if they follow the plan they’ll get shredded like you.

To be totally honest for a minute: steroid use is fairly common among athletes who compete in sports that are not drug tested, or who don’t compete at all. But because it is illegal for recreational use in some places, many folks don’t want to talk about it. (There are exceptions, though: here’s a before-and-after post from sport scientist and bodybuilder Mike Israetel where he obliquely compares his “natural” years to the part of his training career that was “otherwise.”)

Don’t forget that influencers often use photo editing — with Photoshop, FaceTune, and other software — to make themselves look skinnier (or curvier) as needed. Posing to accentuate certain body parts is absolutely an art that can be taken to extraordinary lengths, as journalist Danae Mercer points out in several subversive little tutorials on her feed. Oh, and: if you’re looking at influencers selling booty workout plans, be aware that butt implants are very much a thing.

What is this person’s real area of expertise?

If somebody is selling diet plans, exercise programs, or coaching services, they should have credentials — formal or otherwise — to back them up. For example, a personal training certification from a legit organisation like ACE, ACSM, NSCA, or another accredited by NCAA is one thing to look for. Some coaches or instructors don’t have a formal credential, but can point to top athletes they’ve coached or fellow professionals who can vouch for them. These more subjective connections work best if you follow them to find the trainer or instructor in the first place: for example, if several of your favourite powerlifters are all coached by the same person, that person may be a good source of advice for you.

But remember that exercise and nutrition are not the same thing. If someone is giving advice on nutrition, check whether they are a registered dietitian or hold a similar qualification. In many places, “nutritionist” is not a legally defined

Read more

Bayer to acquire Asklepios Bio in foray into gene therapy worth up to $4 billion

FRANKFURT (Reuters) – Bayer BAYGn.DE agreed to acquire unlisted U.S. biotech firm Asklepios BioPharmaceutical Inc for as much as $4 billion in a bet on gene therapy with the help of modified viruses.

FILE PHOTO: A bridge is decorated with the logo of a Bayer AG, a German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File Photo

Germany’s Bayer will pay $2 billion upfront and up to an additional $2 billion in milestone payments contingent on development achievements, it said on Monday.

The North Carolina-based takeover target, also known as AskBio, is trying to use the harmless adeno-associated virus as a delivery device to bring genetic repair kits against a range of diseases into the body.Drugs and farming pesticides maker Bayer needs to upgrade its drug development pipeline amid a weaker outlook for agricultural sales and as it seeks to finalise an $11 billion settlement over claims its Roundup weedkiller causes cancer.

Among AskBio’s most advanced projects are early tests on volunteers of prospective treatments against Pompe disease – a rare genetic disease causing buildup of a sugar molecule inside cells – as well as against Parkinson’s disease and congestive heart failure.

Bayer said the deal complements the 2019 acquisition of BlueRock Therapeutics, a developer of stem cell therapies, and underscores Bayer’s intention to create a cell and gene therapy business.

AskBio, which was founded in 2001, and BlueRock will exchange information and collaborate but will each operate as independent entities, prompting a pledge from AskBio’s five main owners, who are co-founders or key scientists, to remain with the firm.

“We are staying on board because of the unique structure that Bayer has provided … We’ll have the ability to make our science decisions,” said Chief Executive Officer and co-founder Sheila Mikhail.

Investors TPG Capital and Vida Ventures are selling a minority stake in the company.

AskBio is also helping other companies with their gene therapy research and production and has licensed experimental drugs to external partners, which has financed much of its own drug development activities. Bayer or AskBio would not provide figures for such fee revenues.

A potential treatment of Duchenne Muscular Dystrophy, invented by AskBio is currently being developed in clinical trials by Pfizer PFE.N and this month won fast track here status from U.S. regulators.

Bayer in 2018 moved to lean more strongly on external firms to improve drug development, which analysts say needs a boost to make up for an expected decline in revenues from its two pharma bestsellers from about 2024.

Credit Suisse was financial advisor while Baker McKenzie was legal counsel to Bayer. JP Morgan was financial advisor to AskBio, while Ropes & Gray was legal counsel.

Reporting by Ludwig Burger; Editing by Frances Kerry

Source Article

Read more

Biomaterials Market Size Worth Around US$ 390.92 Bn by 2027

Precedence Research, Recently Published Report on “Biomaterials Market Size, Share, Growth, Trends Analysis, Segment Forecasts, Regional Outlook 2020 – 2027”.

OTTAWA, Oct. 22, 2020 (GLOBE NEWSWIRE) — The global biomaterials market size was valued at US$ 109.4 Billion in 2019 and expected to reach US$ 390.92 Billion by 2027 and poised to grow at a compound annual growth rate (CAGR) of 15.2% during the forecast period from 2020 to 2027. Get more [email protected] https://www.precedenceresearch.com/biomaterials-market

Biomaterials play an important role in medical industry. They are the derived substance that directly interacts with the biological system for restoring or healing after disease or injury. Biomaterials may be synthetic or natural and are used in medical applications to enhance, support, or replace the damaged tissue or a biological function. Biomaterials are used in broad range of applications that include methods to promote healing of human tissues, medical implants, molecular probes and nanoparticles, regenerated human tissues, drug-delivery system, and biosensors.

Growth Factors

The government of various regions along with universities researching on medical sector has allocated funds for the development of novel biomaterials. The aforementioned factor expected to drive the market growth. For instance, two European Commission programs allotted USD 15.6 Billion for research on biomaterials for a period of five years from 2013 to 2017. Similarly, in March 2018, Drexel University issued USD 200,000 to the National Science Foundation for researching on how biomaterial vascularization gets affected from the biomaterial-mediated control over macrophage behavior.

However, in various regions such as Asia Pacific, Europe, and North America, government has stringent regulations for the application of biomaterial-based medical devices to ensure their efficacy and quality. The above mentioned factor expected to hamper the market growth in the coming years.

Get the Sample Pages of Report for More [email protected] https://www.precedenceresearch.com/sample/1059

Report Highlights

  • In 2019, North America led the global biomaterials market due to initiatives taken by different private and public organizations. Furthermore, increasing number of surgeries along with the presence of numerous market players in the region account for the significant growth of the market.

  • The Asia Pacific anticipated witnessing the fastest growth during the analysis period. This is attributed to the major strategies adopted by the regional players to reinforce their presence in both global as well as regional market.

  • Based on product, polymer segment led the global biomaterials market with considerable revenue share in 2019 and projected to continue its dominance in the coming years. This is mainly attributed to the wide range of applications of polymer products. Besides this, natural biomaterials anticipated to register the highest growth rate over the forecast period due to numerous benefits offered by the product over synthetic biomaterials related to biocompatibility, biodegradability, and remodeling.

  • By application, the orthopedic segment captured maximum revenue share in the global biomaterials market in 2019. Rising adoption of metallic biomaterials owing to their high load bearing capacity is one of the prime factors that drive the growth of the segment. Besides this, significant developments and on-going investments for the advancement in

Read more

Research Antibodies and Reagents Market worth $14.1 Billion by 2025

CHICAGO, Oct. 20, 2020 /PRNewswire/ — According to the new market research report Research Antibodies and Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blotting, Flow Cytometry), Application (Proteomics, Drug Development), End User – COVID-19 Impact – Global Forecast to 2025“, published by MarketsandMarkets™, the global market size is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period.

MarketsandMarkets Logo
MarketsandMarkets Logo

The growth is due to evolution of market owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research reproducibility, and increasing R&D activity and expenditure in the life sciences industry. Fueled by the growing demand for personalized medicine and structure-based drug design, the global market is expected to witness significant growth in the coming years.

Browse in-depth TOC on “Research Antibodies and Reagents Market”

220 – Tables
45 – Figures
278 – Pages

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793

The COVID-19 outbreak has boosted research activity due to efforts to understand the dynamics of the infection. We estimate that the major share of research antibody and reagent manufacturing, along with personalized medicine, will grow at a stable pace in the next five years. Due to the increase in research activity, both the availability of funding for research and the demand & manufacturing of reagents and antibodies are expected to grow. As companies after pandemic have scaled up their operations for testing and tracking the infection of COVID-19. This has given a chance for growth in profits for companies operating in the NGS and PCR markets. The growth in revenue is 5–7%, as COVID-19 testing has increased with the use of the latest technology of genetic and molecular testing. The shift in demand for research for COVID-19, neurobiology, and oncology has created a huge scope for testing solutions, such as western blotting, flow cytometry, ELISA, and drugs for researchers and laboratories.

The antibodies segment is expected to grow at the highest CAGR during the forecast period

Based on product, the research antibodies market is segmented into reagents and antibodies. The antibodies segment is expected to grow at highest CAGR in forecast period. This is due to the research-use antibodies offer high specificity and selectivity and are used ubiquitously in biochemical and medical research for protein-target identification, regulatory characterization, and discovery.

The primary antibodies segment is accounts for the largest share of the research reagents market

Based type, the research reagents market is segmented into primary antibodies and secondary antibodies. The primary antibodies segment held the largest share of the global research antibodies market in 2019. This segment is witnessing a strong growth due to the use of these antibodies in numerous types of assay formats. Their accuracy in biomarker detection and their high specificity and sensitivity are also driving their adoption

The media & sera reagent is expected to account for the largest share of the market, by type, in 2019

Read more